MetaStat
Boston, US · Founded 2007 · Nevada corporation
Find your way into MetaStat
Sign up to see every warm intro you have to MetaStat
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MetaStat team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Board
RJ
Richard J. BermanBoard director
DN
David N. SiegelBoard director
DM
David M. EpsteinBoard director
HP
H. Philip GoodeveBoard director
J(
Johan (Thijs) L. SpoorBoard director
HJ
Harvey JudkowitzBoard director
Reported raises · per SEC filings
Form D private placements$16.5M disclosed across 12 of 14 rounds · 2012–2018
▶$3.4MraisedApr 2018 · 6 investors · BiotechnologyRule 506(b)
▶$3.4MraisedApr 2018 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Douglas A. HamiltonExecutive Officer, Director
- Paul A. BillingsDirector
- Daniel H. SchneidermanExecutive Officer
- Jerome B. ZeldisDirector
- Offering amount
- $3.6M
- Amount sold
- $3.4M
- Sales commissions
- $100K
- Placement agents
- COVA Capital Partners, LLC
- First sale
- Mar 2018
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$2.1MraisedJul 2017 · 14 investors · BiotechnologyRule 506(b)
▶$2.1MraisedJul 2017 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Douglas A. HamiltonExecutive Officer, Director
- Jerome B. ZeldisDirector
- Daniel H. SchneidermanExecutive Officer
- Paul A. BillingsDirector
- Offering amount
- $7M
- Amount sold
- $2.1M
- Sales commissions
- $157.4K
- Placement agents
- COVA Capital Partners, LLC
- First sale
- Jun 2017
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$87.5KraisedSep 2016 · 1 investors · BiotechnologyRule 506(b)
▶$87.5KraisedSep 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Daniel H. SchneidermanExecutive Officer
- H. Philip GoodeveDirector
- Jerome A. ZeldisDirector
- Johan (Thijs) A. SpoorDirector
- Douglas A. HamiltonExecutive Officer
- Martin J. DriscollDirector
- Richard J. BermanDirector
- Oscar L. BronstherDirector
- Offering amount
- $20M
- Amount sold
- $87.5K
- Sales commissions
- $875
- Placement agents
- COVA Capital Partners, LLC
- First sale
- Aug 2016
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$495KraisedJun 2016 · 11 investors · BiotechnologyRule 506(b)
▶$495KraisedJun 2016 · 11 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard J. BermanDirector
- Daniel H. SchneidermanExecutive Officer
- Johan (Thijs) A. SpoorDirector
- Douglas A. HamiltonExecutive Officer
- Martin J. DriscollDirector
- H. Philip GoodeveDirector
- Jerome A. ZeldisDirector
- Oscar L. BronstherDirector
- Offering amount
- $5M
- Amount sold
- $495K
- Sales commissions
- $41K
- Placement agents
- H.C. Wainwright and Co. LLC, COVA Capital Partners, LLC
- First sale
- May 2016
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$350KraisedFeb 2016 · 4 investors · BiotechnologyRule 506(b)
▶$350KraisedFeb 2016 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Douglas A. HamiltonExecutive Officer
- H. Philip GoodeveDirector
- Daniel H. SchneidermanExecutive Officer
- Johan (Thijs) A. SpoorDirector
- Martin J. DriscollDirector
- Richard J. BermanDirector
- Oscar L. BronstherDirector
- Offering amount
- $1M
- Amount sold
- $350K
- First sale
- Feb 2016
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1.2MraisedAug 2015 · 1 investors · BiotechnologyRule 506(b)
▶$1.2MraisedAug 2015 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard J. BermanDirector
- Oscar L. BronstherDirector
- H. Philip GoodeveDirector
- Daniel H. SchneidermanExecutive Officer
- Martin J. DriscollDirector
- Douglas A. HamiltonExecutive Officer
- Johan (Thijs) A. SpoorDirector
- Offering amount
- $1.2M
- Amount sold
- $1.2M
- Sales commissions
- $84K
- First sale
- Jul 2015
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$1.3MraisedJan 2015 · 5 investors · BiotechnologyRule 506(b)
▶$1.3MraisedJan 2015 · 5 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Richard J. BermanDirector
- Oscar L. BronstherExecutive Officer, Director
- David N. SiegelDirector
- David M. EpsteinDirector
- H. Philip GoodeveDirector
- Johan (Thijs) L. SpoorDirector
- Daniel H. SchneidermanExecutive Officer
- Offering amount
- $3.5M
- Amount sold
- $1.3M
- Sales commissions
- $80.1K
- Placement agents
- H.C. Wainwright and Co. LLC
- First sale
- Dec 2014
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
▶$280.7KraisedOct 2014 · 1 investors · BiotechnologyRule 506(b)
▶$280.7KraisedOct 2014 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David M. EpsteinDirector
- Oscar BronstherExecutive Officer, Director
- Daniel H. SchneidermanExecutive Officer
- H. Philip GoodeveDirector
- David N. SiegelDirector
- Johan (Thijs) SpoorDirector
- Richard J. BermanDirector
- Offering amount
- $280.7K
- Amount sold
- $280.7K
- First sale
- Oct 2014
- Incorporated
- Corporation, Nevada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has MetaStat raised?
- MetaStat has disclosed $16.5M raised across 12 of its 14 known rounds.
- Where is MetaStat headquartered?
- MetaStat is headquartered in Boston, US.